Construction and application of anticoagulation monitoring informatization module for extracorporeal membrane oxygenation patients
10.3760/cma.j.cn115682-20240107-00141
- VernacularTitle:体外膜肺氧合患者抗凝监测信息化模块的构建及应用
- Author:
Chen XIN
1
;
Yubiao GAI
;
Wenbin JIANG
;
Hui TIAN
;
Yan ZHANG
;
Lili WEI
Author Information
1. 青岛大学附属医院西海岸院区重症医学科，青岛 266500
- Publication Type:Journal Article
- Keywords:
Extracorporeal membrane oxygenation;
Anticoagulation;
Informatization;
Process
- From:
Chinese Journal of Modern Nursing
2025;31(10):1278-1283
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To optimize the anticoagulation monitoring process for extracorporeal membrane oxygenation (ECMO) patients by constructing an informatization module and evaluate its application effect.Methods:An informatization team was established, and based on literature review, an anticoagulation monitoring information sheet for ECMO patients was developed. Using a data-sharing architecture, existing hospital information management system, laboratory information management system, picture archiving and communication system, and ICU monitoring system were integrated to construct an ECMO anticoagulation monitoring informatization module with data sharing, real-time alerts, and information support functions. Clinical applications were observed for effect. A convenience sampling method was employed to select 60 ECMO patients treated in the ICU of the Affiliated Hospital of Qingdao University from October 2022 to September 2023. The patients admitted from October 2022 to March 2023 were designated as the control group ( n=30), using the conventional anticoagulation monitoring method; those admitted from April to September 2023 were designated as the experimental group ( n=30), using the anticoagulation monitoring informatization module. The anticoagulation monitoring timeliness rate, anticoagulant drug adjustment timeliness rate, and the incidence rates of thrombosis and bleeding were compared between the two groups. Results:The timeliness rate of anticoagulation monitoring and the timeliness rate of anticoagulant drug adjustment in the experimental group were (93.38±6.31) % and (91.90±4.71) %, respectively, which were higher than those in the control group (83.01±9.94) % and (83.49±12.83) %, with statistically significant differences (both P<0.01). The incidence rates of thrombosis and bleeding in the experimental group were 16.67% (5/30) and 26.67% (8/30), respectively, which were lower than those in the control group 40.00% (12/30) and 53.33% (16/30), with statistically significant differences (both P<0.05) . Conclusions:The optimized anticoagulation monitoring informatization process based on the anticoagulation monitoring informatization module demonstrates a good clinical application effect and can reduce the incidence of bleeding and thrombosis in ECMO patients.
